Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device
Primary Purpose
Anaphylaxis
Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Device: Anapphylaxis
Sponsored by
About this trial
This is an interventional supportive care trial for Anaphylaxis
Eligibility Criteria
Inclusion Criteria:
- Patients 18 years old or above
- Patients diagnosed with Anaphylaxis and an epinephrine auto-injector prescribed
- Patients with a smartphone
- Patients who signed the informed consent
Exclusion Criteria:
- Patients who have not signed the informed consent
- Patients with some limitations for understanding or following correctly the trial procedures
- Pregnant or nursing women
Sites / Locations
- Hospital Vall d'Hebron
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
epinephrine auto-injector
epinephrine auto-injector + medical device
Arm Description
3 months using the epinephrine auto-injector alone, and after that 3 more months using the epinephrine auto-injector + medical device
Device: Anapphylaxis is a medical device with a case for an epinephrine autoinjector that connects via Bluetooth to a mobile application 3 months using the epinephrine auto-injector + medical device , and after that 3 more months using the epinephrine auto-injector alone
Outcomes
Primary Outcome Measures
Patient satisfaction through a questionnaire in the use of the medical device
Secondary Outcome Measures
Medical device safety
Adverse events related to the medical device
Patient Adherence to the medical device through a questionnaire
Full Information
NCT ID
NCT02854969
First Posted
July 22, 2016
Last Updated
July 25, 2017
Sponsor
Adan Medical Innovation, SL
1. Study Identification
Unique Protocol Identification Number
NCT02854969
Brief Title
Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device
Official Title
Randomized, Cross-over, Open, Unicentric Trial Evaluating Satisfaction With the Use of a Medical Device for the Epinephrine Auto-injector in Patients With Anaphylaxis
Study Type
Interventional
2. Study Status
Record Verification Date
August 2016
Overall Recruitment Status
Completed
Study Start Date
May 2016 (undefined)
Primary Completion Date
July 18, 2017 (Actual)
Study Completion Date
July 18, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Adan Medical Innovation, SL
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Through several questionaries the investigators will measure the satisfaction of patients diagnosed with anaphylaxis in the use of a medical device for the adrenaline autoinjector, a smart case for an epinephrine autoinjector connected via Bluetooth to a mobile application.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anaphylaxis
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
epinephrine auto-injector
Arm Type
No Intervention
Arm Description
3 months using the epinephrine auto-injector alone, and after that 3 more months using the epinephrine auto-injector + medical device
Arm Title
epinephrine auto-injector + medical device
Arm Type
Experimental
Arm Description
Device: Anapphylaxis is a medical device with a case for an epinephrine autoinjector that connects via Bluetooth to a mobile application
3 months using the epinephrine auto-injector + medical device , and after that 3 more months using the epinephrine auto-injector alone
Intervention Type
Behavioral
Intervention Name(s)
Device: Anapphylaxis
Primary Outcome Measure Information:
Title
Patient satisfaction through a questionnaire in the use of the medical device
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Medical device safety
Description
Adverse events related to the medical device
Time Frame
3 months
Title
Patient Adherence to the medical device through a questionnaire
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients 18 years old or above
Patients diagnosed with Anaphylaxis and an epinephrine auto-injector prescribed
Patients with a smartphone
Patients who signed the informed consent
Exclusion Criteria:
Patients who have not signed the informed consent
Patients with some limitations for understanding or following correctly the trial procedures
Pregnant or nursing women
Facility Information:
Facility Name
Hospital Vall d'Hebron
City
Barcelona
ZIP/Postal Code
08035
Country
Spain
12. IPD Sharing Statement
Learn more about this trial
Satisfaction of Patient With Anaphylaxis in the Use of a Medical Device
We'll reach out to this number within 24 hrs